 | Up a level |
Meliga, E; Garcia-Garcia, H M; Valgimigli, M; Chieffo, A; Biondi-Zoccai, G; Maree, A O; Gonzalo, N; Cook, S; Marra, S; Moretti, C; De Servi, S; Palacios, I F; Windecker, S; van Domburg, R; Colombo, A; Sheiban, I; Serruys, P W (2009). Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT). International journal of cardiology, 137(1), pp. 16-21. Amsterdam: Elsevier 10.1016/j.ijcard.2008.06.006
Daemen, Joost; Simoons, Maarten L; Wijns, William; Bagust, Adrian; Bos, Gert; Bowen, James M; Braunwald, Eugene; Camenzind, Edoardo; Chevalier, Bernard; Dimario, Carlo; Fajadet, Jean; Gitt, Anselm; Guagliumi, Giulio; Hillege, Hans L; James, Stefan; Jüni, Peter; Kastrati, Adnan; Kloth, Sabine; Kristensen, Steen D; Krucoff, Mitchell; ... (2009). ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. European Heart Journal, 30(2), pp. 152-61. Oxford: Oxford University Press
